Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Hawkins, Vivian N ^a   Auliff, Alyson ^b   Prajapati, Surendra Kumar ^c   Rungsihirunrat, Kanchana ^d   Hapuarachchi, Hapuarachchige C ^e   Maestre, Amanda ^f   O'Neil, Michael T ^b,g   Cheng, Qin ^b   Joshi, Hema ^c   Na Bangchang, Kesara ^h   Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Australian Army Medical Institute   (Australia)

^c NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e UNIVERSITY OF KELANIYA   (Sri Lanka)

^f UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^g WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^h THAMMASAT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; ANTIMALARIAL AGENT; PROTOZOAL DNA; PYRIMETHAMINE;

ARTICLE; COLOMBIA; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC RESISTANCE; HAPLOTYPE; HUMAN; INDIA; INDONESIA; MAJOR CLINICAL STUDY; NONHUMAN; PAPUA NEW GUINEA; PLASMODIUM VIVAX; SINGLE NUCLEOTIDE POLYMORPHISM; SRI LANKA; THAILAND; VANUATU; ANIMAL; CODON; DRUG EFFECT; DRUG RESISTANCE; GENETICS; ISOLATION AND PURIFICATION; MALARIA; MUTATION; PARASITOLOGY;

ANIMALS; ANTIMALARIALS; CODON; DNA, PROTOZOAN; DRUG RESISTANCE; MALARIA, VIVAX; MUTATION; PLASMODIUM VIVAX; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRIMETHAMINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 43549097131     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-72     Document Type: Article

References (30)

1. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? CH Sibley JE Hyde PF Sims CV Plowe JG Kublin EK Mberu AF Cowman PA Winstanley WM Watkins AM Nzila, Trends Parasitol 2001 17 582 588 10.1016/S1471-4922(01) 02085-2 11756042
2. Chloroquine-resistant malaria. TE Wellems CV Plowe, J Infect Dis 2001 184 770 776 10.1086/322858 11517439
3. Chloroquine Resistance in Plasmodium vivax. JK Baird, Antimicrob Agents Chemother 2004 48 4075 4083 15504824 10.1128/AAC.48.11.4075-4083.2004
4. Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria. M Mayxay S Pukritrayakamee K Chotivanich M Imwong S Looareesuwan NJ White, Am J Trop Med Hyg 2001 65 588 592 11716119
5. Mixed-species malaria infections in humans. M Mayxay S Pukrittayakamee PN Newton NJ White, Trends Parasitol 2004 20 233 240 10.1016/j.pt.2004.03.006 15105024
6. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. G Snounou NJ White, Trends Parasitol 2004 20 333 339 10.1016/j.pt.2004.05.004 15193565
7. Mechanisms of resistance of malaria parasites to antifolates. A Gregson CV Plowe, Pharmacol Rev 2005 57 117 145 10.1124/pr.57.1.4 15734729
8. Antifolates can have a role in the treatment of Plasmodium vivax. VN Hawkins H Joshi K Rungsihirunrat K Na-Bangchang CH Sibley, Trends Parasitol 2007 23 213 222 10.1016/j.pt.2007.03.002 17368986
9. Exploring the folate pathway in Plasmodium falciparum. JE Hyde, Acta Trop 2005 94 191 206 15845349
10. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. MT Alam H Bora PK Bharti MA Saifi MK Das V Dev A Kumar N Singh AP Dash B Das, Antimicrob Agents Chemother 2007 51 857 863 17194833 10.1128/AAC.01200-06
11. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. AM McCollum K Mueller L Villegas V Udhayakumar AA Escalante, Antimicrob Agents Chemother 2007 51 2085 2091 17283199 10.1128/AAC.01228-06
12. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. AM McCollum AC Poe M Hamel C Huber Z Zhou YP Shi P Ouma J Vulule P Bloland L Slutsker, J Infect Dis 2006 194 189 197 10.1086/504687 16779725
13. A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. S Nair JT Williams A Brockman L Paiphun M Mayxay PN Newton JP Guthmann FM Smithuis TT Hien NJ White, Mol Biol Evol 2003 20 1526 1536 10.1093/molbev/msg162 12832643
14. Selection strength and hitchhiking around two anti-malarial resistance genes. D Nash S Nair M Mayxay PN Newton JP Guthmann F Nosten TJ Anderson, Proc Biol Sci 2005 272 1153 1161 16024377 10.1098/rspb.2004.3026
15. Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal. D Ndiaye JP Daily O Sarr O Ndir O Gaye S Mboup C Roper DF Wirth, Acta Trop 2006 99 106 111 10.1016/j.actatropica.2006.07.002 16905111
16. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. C Roper R Pearce B Bredenkamp J Gumede C Drakeley F Mosha D Chandramohan B Sharp, Lancet 2003 361 1174 1181 10.1016/S0140-6736(03) 12951-0 12686039
17. Intercontinental spread of pyrimethamine-resistant malaria. C Roper R Pearce S Nair B Sharp F Nosten T Anderson, Science 2004 305 1124 10.1126/science.1098876 15326348
18. Extensive heterozygosity at four microsatellite loci flanking Plasmodium vivax dihydrofolate reductase gene. MT Alam R Agarwal YD Sharma, Mol Biochem Parasitol 2007 153 178 185 10.1016/j.molbiopara.2007.03.003 17418906
19. Mapping drug resistance genes in Plasmodium falciparum by genome-wide association. TJ Anderson, Curr Drug Targets Infect Disord 2004 4 65 78 10.2174/1568005043480943 15032635
20. Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment. L Musset J Le Bras J Clain, Mol Biol Evol 2007 24 1582 1585 10.1093/molbev/msm087 17488741
21. Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. S Nair D Nash D Sudimack A Jaidee M Barends AC Uhlemann S Krishna F Nosten TJ Anderson, Mol Biol Evol 2007 24 562 573 10.1093/molbev/msl185 17124182
22. The Plasmodium vivax genome sequencing project. J Carlton, Trends Parasitol 2003 19 227 231 10.1016/S1471-4922(03)00066-7 12763429
23. Studies of comparative infectivity of fifteen strains of Plasmodium vivax to laboratory-reared anopheline mosquitoes, with special reference to Anopheles culicifacies. WE Collins M Warren AY Huong JC Skinner BB Sutton PS Stanfill, J Parasitol 1986 72 521 524 10.2307/3281501 3537255
24. Plasmodium vivax transmitted from man to monkey to man. MD Young JA Porter Jr CM Johnson, Science 1966 153 1006 1007 10.1126/science.153.3739.1006 4958354
25. Median-joining networks for inferring intraspecific phylogenies. HJ Bandelt P Forster A Rohl, Mol Biol Evol 1999 16 37 48 10331250
26. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. P Eldin de Pecoulas LK Basco R Tahar T Ouatas A Mazabraud, Gene 1998 211 177 185 10.1016/S0378-1119(98)00118-8 9573357
27. A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. X Su MT Ferdig Y Huang CQ Huynh A Liu J You JC Wootton TE Wellems, Science 1999 286 1351 1353 10.1126/science.286.5443.1351 10558988
28. Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum. S Paget-McNicol A Saul, Parasitology 2001 122 497 505 10.1017/S0031182001007739 11393822
29. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. KI Barnes NJ White, Acta Trop 2005 94 230 240 15878154
30. The origins and spread of antimalarial drug resistance: lessons for policy makers. TJ Anderson C Roper, Acta Trop 2005 94 269 280 15878153